Complications of long-acting somatostatin analogue therapy. 1989

J A Jackson

UI MeSH Term Description Entries
D002769 Cholelithiasis Presence or formation of GALLSTONES in the BILIARY TRACT, usually in the gallbladder (CHOLECYSTOLITHIASIS) or the common bile duct (CHOLEDOCHOLITHIASIS). Gallstone Disease,Cholelithiases,Gallstone Diseases
D005243 Feces Excrement from the INTESTINES, containing unabsorbed solids, waste products, secretions, and BACTERIA of the DIGESTIVE SYSTEM.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015282 Octreotide A potent, long-acting synthetic SOMATOSTATIN octapeptide analog that inhibits secretion of GROWTH HORMONE and is used to treat hormone-secreting tumors; DIABETES MELLITUS; HYPOTENSION, ORTHOSTATIC; HYPERINSULINISM; hypergastrinemia; and small bowel fistula. Octreotide Acetate,Compound 201-995,Octreotide Acetate Salt,SAN 201-995,SM 201-995,SMS 201-995,Sandostatin,Sandostatine,Sandoz 201-995,Compound 201 995,Compound 201995,SAN 201 995,SAN 201995,SM 201 995,SM 201995,SMS 201 995,SMS 201995,Sandoz 201 995,Sandoz 201995

Related Publications

J A Jackson
December 1989, The British journal of surgery,
J A Jackson
October 1990, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
J A Jackson
January 1988, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
J A Jackson
January 2007, Developments in ophthalmology,
J A Jackson
June 2002, Annals of the rheumatic diseases,
J A Jackson
January 1985, British medical journal (Clinical research ed.),
J A Jackson
December 1989, Scandinavian journal of gastroenterology,
Copied contents to your clipboard!